Rapid Nutrition Advances Regional Growth Strategy Following Successful 618 Festival Execution
Brand momentum accelerates across China and the U.S. as global expansion plans progress.
London, United Kingdom – 16 June 2025 – Rapid Nutrition PLC (Euronext Growth: ALRPD), an international HealthTech and wellness company, today provides an update on its expanding operations following the successful execution of its 618 Shopping Festival campaign in China. The company also outlines its broader regional strategy as momentum builds across Asia, the United States, and Europe.
“618 was a pivotal milestone for us,” said Simon St. Ledger, CEO of Rapid Nutrition. “We saw strong demand signals and improved conversion across channels, validating our localized approach and brand positioning. More importantly, it reinforced China’s potential to become a long-term growth engine for the business.”
618 Campaign Delivers Early Results, Sets Stage for Continued China Growth
Rapid Nutrition’s participation in China’s mid-year 618 Shopping Festival marked a new level of regional engagement. Highlights from the campaign include:
- Record Monthly Sales: 5,262 units sold in the past 30 days, up 142% month-over-month
- Surging Traffic & Conversion: 302,765 store visits (+17.2%) and 954 paying customers (+78.7%)
- Improved Basket Size: Average order value increased 28.1%, reflecting greater product mix adoption
- KOL Activation: A growing number of influencers livestreamed SystemLS to thousands of engaged followers on Douyin, driving awareness and real-time conversions
To support sustained growth, Rapid Nutrition expanded its China-based production capacity and fulfillment capabilities. The company now operates two warehouses and two e-commerce storefronts in China, backed by a local team and content partners focused on optimizing consumer engagement and long-term retention.
Scalable Model Extends Beyond China
Rapid Nutrition’s direct-to-consumer and digitally focused operating model continues to gain traction across key international markets:
- United States: Subscription-based distribution is scaling efficiently, supported by local manufacturing and strong consumer retention. The company is also leveraging its inclusion in a major U.S. clinical study targeting sustainable weight loss in women aged 50+ to build credibility and long-term consumer trust.
- Europe: The company is in active discussions with leading distributors across the region, targeting entry into high-growth plant-based nutrition markets with its SystemLS product range.
- Product Innovation & Clinical Validation: SystemLS remains central to the company’s strategy, offering clean-label weight management solutions backed by science and aligned with consumer demand for transparency and efficacy.
Positioned in a High-Growth Sector with Strengthening Demand
With strategic infrastructure now in place and performance accelerating across key regions, Rapid Nutrition is increasingly well-positioned within the global wellness sector. Recent increases in trading volume reflect broader market interest in companies operating at the intersection of personalized nutrition, digital health, and consumer wellness—especially those showing operational discipline and scalable growth strategies.
Key factors underpinning the company’s continued momentum include:
- Efficient Market Entry: Leveraging localized production, KOL-driven marketing, and direct-to-consumer channels to reduce overhead and drive brand awareness
- Favourable Sector Trends: Tapping into sustained global demand for weight management and functional nutrition products
- Long-Term Execution Plan: Continued focus on targeted capital deployment, partner-driven scalability, and data-informed product development
“As we scale across China, the U.S., and Europe, our mission remains the same: deliver high-quality, science-backed wellness products that fit into modern lifestyles,” added St. Ledger. “Our execution in the first half of the year has laid a strong operational and strategic foundation. As these efforts continue to flow through, we expect them to anchor second-half performance and support meaningful revenue progression.”
About Rapid Nutrition
Rapid Nutrition is a global HealthTech company dedicated to advancing wellness through evidence-based, personalized nutrition solutions. Leveraging advanced technologies, AI, and scientific research, the company is committed to optimizing nutrition, improving health outcomes, and fostering sustainable, healthier lifestyles worldwide.
Investor Relations Contact:
Disclaimer
This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and or otherwise that involve risks, uncertainties and assumptions that could cause Rapid Nutrition PLCs actual results and experience to differ materially from anticipated results and expectations expressed in these forward-looking statements. Rapid Nutrition PLC has in some cases identified forward-looking statements by using words such as "anticipates," "believes," "hopes," "estimates," "looks," "expects," "plans," "intends," "goal," "potential," "may," "suggest," and similar expressions. Rapid Nutrition PLC undertakes no obligation to release publicly the results of any revisions to any such forward-looking statements that may be made to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events, except as required by applicable law or regulation.
This media information does not constitute an offer to sell, or a solicitation of an offer to buy, any securities. This information does not constitute an offering prospectus within the meaning within the meaning of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 of June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, and repealing Directive 2003/71 or a listing prospectus within the meaning of the listing rules of the Euronext Exchange or OTC Markets. The media release is in accordance with International Reporting Standard: Rule 12g3-2(b) under the Securities Exchange Act ('Rule 12g3-2(b)') permits non-U.S. companies with securities listed primarily on a Qualified Foreign Exchange to make publicly available to U.S investors in English the same information that is made publicly available in their home countries as an alternative to SEC reporting Exchange Act Rule 12g3-2(b).